Annual Revenue:
$57.56M+$6.98M(+13.80%)Summary
- As of today, AQST annual revenue is $57.56 million, with the most recent change of +$6.98 million (+13.80%) on December 31, 2024.
- During the last 3 years, AQST annual revenue has risen by +$6.73 million (+13.24%).
- AQST annual revenue is now -14.64% below its all-time high of $67.43 million, reached on December 31, 2018.
Performance
AQST Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$12.81M+$2.80M(+28.03%)Summary
- As of today, AQST quarterly revenue is $12.81 million, with the most recent change of +$2.80 million (+28.03%) on September 30, 2025.
- Over the past year, AQST quarterly revenue has dropped by -$735.00 thousand (-5.43%).
- AQST quarterly revenue is now -52.82% below its all-time high of $27.15 million, reached on September 30, 2017.
Performance
AQST Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$43.40M-$735.00K(-1.67%)Summary
- As of today, AQST TTM revenue is $43.40 million, with the most recent change of -$735.00 thousand (-1.67%) on September 30, 2025.
- Over the past year, AQST TTM revenue has dropped by -$15.50 million (-26.32%).
- AQST TTM revenue is now -43.41% below its all-time high of $76.68 million, reached on June 30, 2018.
Performance
AQST TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AQST Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +13.8% | -5.4% | -26.3% |
| 3Y3 Years | +13.2% | +11.7% | -9.7% |
| 5Y5 Years | +9.4% | +55.0% | -21.3% |
AQST Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +20.7% | -36.3% | +46.9% | -26.3% | at low |
| 5Y | 5-Year | at high | +25.5% | -36.3% | +79.1% | -26.3% | +3.6% |
| All-Time | All-Time | -14.6% | +25.5% | -52.8% | +79.1% | -43.4% | +164.0% |
AQST Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $12.81M(+28.0%) | $43.40M(-1.7%) |
| Jun 2025 | - | $10.00M(+14.7%) | $44.13M(-18.6%) |
| Mar 2025 | - | $8.72M(-26.5%) | $54.23M(-5.8%) |
| Dec 2024 | $57.56M(+13.8%) | $11.87M(-12.4%) | $57.56M(-2.3%) |
| Sep 2024 | - | $13.54M(-32.6%) | $58.90M(+0.9%) |
| Jun 2024 | - | $20.10M(+66.8%) | $58.36M(+13.3%) |
| Mar 2024 | - | $12.05M(-8.7%) | $51.50M(+1.8%) |
| Dec 2023 | $50.58M(+6.1%) | $13.21M(+1.6%) | $50.58M(+5.3%) |
| Sep 2023 | - | $13.00M(-1.8%) | $48.06M(+3.3%) |
| Jun 2023 | - | $13.24M(+18.9%) | $46.52M(-0.1%) |
| Mar 2023 | - | $11.13M(+4.2%) | $46.54M(-2.4%) |
| Dec 2022 | $47.68M(-6.2%) | $10.68M(-6.8%) | $47.68M(-0.8%) |
| Sep 2022 | - | $11.46M(-13.6%) | $48.08M(-3.7%) |
| Jun 2022 | - | $13.27M(+8.1%) | $49.90M(-4.0%) |
| Mar 2022 | - | $12.27M(+10.8%) | $51.98M(+2.3%) |
| Dec 2021 | $50.83M | $11.08M(-16.6%) | $50.83M(+8.4%) |
| Sep 2021 | - | $13.29M(-13.4%) | $46.90M(+12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $15.35M(+38.0%) | $41.88M(-13.1%) |
| Mar 2021 | - | $11.12M(+55.6%) | $48.21M(+5.1%) |
| Dec 2020 | $45.85M(-12.8%) | $7.15M(-13.5%) | $45.85M(-16.8%) |
| Sep 2020 | - | $8.26M(-61.9%) | $55.12M(-7.0%) |
| Jun 2020 | - | $21.68M(+147.3%) | $59.28M(+21.6%) |
| Mar 2020 | - | $8.77M(-46.6%) | $48.73M(-7.4%) |
| Dec 2019 | $52.61M(-22.0%) | $16.42M(+32.2%) | $52.61M(-0.8%) |
| Sep 2019 | - | $12.42M(+11.6%) | $53.01M(-1.6%) |
| Jun 2019 | - | $11.13M(-12.0%) | $53.86M(-4.9%) |
| Mar 2019 | - | $12.64M(-24.9%) | $56.66M(-16.0%) |
| Dec 2018 | $67.43M(+0.8%) | $16.82M(+26.8%) | $67.43M(+7.4%) |
| Sep 2018 | - | $13.27M(-4.7%) | $62.80M(-18.1%) |
| Jun 2018 | - | $13.93M(-40.5%) | $76.68M(+22.2%) |
| Mar 2018 | - | $23.41M(+92.0%) | $62.75M(+12.5%) |
| Dec 2017 | $66.92M(+29.2%) | $12.20M(-55.1%) | $55.78M(+28.0%) |
| Sep 2017 | - | $27.15M(+65.2%) | $43.58M(+165.2%) |
| Mar 2017 | - | $16.44M | $16.44M |
| Dec 2016 | $51.78M | - | - |
FAQ
- What is Aquestive Therapeutics, Inc. annual revenue?
- What is the all-time high annual revenue for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. annual revenue year-on-year change?
- What is Aquestive Therapeutics, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Aquestive Therapeutics, Inc. TTM revenue?
- What is the all-time high TTM revenue for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. TTM revenue year-on-year change?
What is Aquestive Therapeutics, Inc. annual revenue?
The current annual revenue of AQST is $57.56M
What is the all-time high annual revenue for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high annual revenue is $67.43M
What is Aquestive Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, AQST annual revenue has changed by +$6.98M (+13.80%)
What is Aquestive Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of AQST is $12.81M
What is the all-time high quarterly revenue for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high quarterly revenue is $27.15M
What is Aquestive Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, AQST quarterly revenue has changed by -$735.00K (-5.43%)
What is Aquestive Therapeutics, Inc. TTM revenue?
The current TTM revenue of AQST is $43.40M
What is the all-time high TTM revenue for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high TTM revenue is $76.68M
What is Aquestive Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, AQST TTM revenue has changed by -$15.50M (-26.32%)